Vascular dysfunction in pulmonary hypertension: Role of protein kinase G-1α nitration

S Aggarwal - 2011 - search.proquest.com
Pulmonary vasodilation is mediated through the activation of protein kinase G (PKG) via a
signaling pathway involving nitric oxide (NO), natriuretic peptides (NP), and cyclic …

Avaliação quantitativa de VEGF A por qRT-PCR em fígados de pacientes com Atresia Biliar

PPL Lima - 2010 - lume.ufrgs.br
A Atresia Biliar, principal causa de transplante hepático em crianças, tem causa obscura.
Para avaliar a presença de uma arteriopatia como causa da doença investigamos a …

Vascular Endothelial Growth Factor and Pulmonary Injury

V Bhandari - Principles of Pulmonary Protection in Heart Surgery, 2010 - Springer
Vascular endothelial growth factor (VEGF) is a pluripotent growth factor that is essential for
lung development 1, 2 and has significant regulatory roles in angiogenesis and vascular …

Novel Anti-Proliferative Therapies in Pulmonary Hypertension

W Janssen, RT Schermuly - Pulmonary Arterial Hypertension, 2010 - ebooks.iospress.nl
Pulmonary arterial hypertension is a vasculoproliferative disorder of the small pulmonary
arteries, which is characterized by vasoconstriction and proliferation of the vascular cells in …

Idiopathic and Familial Pulmonary Arterial Hypertension

JM Elwing, GH Deutsch, WC Nichols… - Molecular Basis of …, 2010 - Springer
Pulmonary arterial hypertension (PAH) is a progressive, fatal disease that is defined
hemodynamically. The average life expectancy after diagnosis is short, with death usually …

[图书][B] Die Entwicklung eines neuen Tiermodells der pulmonalen Hypertonie und therapeutischer Interventionen

K Helmus - 2010 - jlupub.ub.uni-giessen.de
Die pulmonalarterielle Hypertonie des Menschen ist eine schwierig zutherapierende
Erkrankung, die unbehandelt zum Tode führen kann. Die PAH istgekennzeichnet durch eine …

DELINEATING THE ANGIOGENIC GENE EXPRESSION PROFILE PRIOR 1 TO PULMONARY VASCULAR REMODELING IN A LAMB MODEL OF 2 CONGENITAL …

X She, JR Fineman, SM Black… - CONGENITAL HEART …, 2010 - journals.physiology.org
Running Title: Microarray studies in 3-day Shunts 14 Please address correspondence and
proofs to: 15 Stephen M. Black, Ph. D. 16 Vascular Biology Center: CB-3211B 17 Medical …

[PDF][PDF] Gene expression profile in flow-associated pulmonary

RGS Dickinson, K Kooi, F Gerbens… - Am J Physiol Lung Cell …, 2010 - researchgate.net
METHODS Animal model. Twenty-four male Wistar rats (Harlan) weighing 250–300 g were
used. Animal care and experiments were conducted according to the Dutch Animal …

[PDF][PDF] Przetoki naczyniowe

J Skalski, I Kovalenko - 2021 - kardiochirurgiadziecieca.cm-uj …
Przetoki naczyniowe są nieprawidłowymi połączeniami w układach:–tętniczo-żylnym,–
tętniczo-tętniczym,–żylno-żylnym. Grupę największą, obejmującą w przytłaczającej …

Differential Regulation of Endothelial Cell Barrier Function

JR Jacobson, SM Dudek… - Endothelial Cells in Health …, 2005 - taylorfrancis.com
The endothelium serves as a semipermeable barrier separating the circulation from the
surrounding interstitium. Its luminal surface is coated with a negatively charged glycocalyx …